CEGABA is widely used in the pharmaceutical industry as an intermediate in the synthesis of gamma-aminobutyric acid (GABA) analogs, which exhibit neuroactive properties. It plays a key role in the development of drugs targeting neurological disorders such as epilepsy, anxiety, and insomnia. Due to its structural compatibility with neurotransmitter systems, it is also explored in the design of prodrugs aimed at improving blood-brain barrier penetration. In research settings, CEGABA serves as a building block for novel compounds in medicinal chemistry, particularly in creating modulators of GABA receptors. Its utility extends to the preparation of labeled derivatives for metabolic and receptor binding studies.